Anixa Biosciences Inc - Common Stock (ANIX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ANIX on Nasdaq
Shares outstanding
35,258,614
Price per share
$3.12
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,413,922
Total reported value
$17,872,434
% of total 13F portfolios
0%
Share change
+92,922
Value change
+$304,259
Number of holders
65
Price from insider filings
$3.12
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Anixa Biosciences Inc - Common Stock (ANIX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KUMAR AMIT 16% +8% $16,667,362 +$1,403,336 6,173,097 +9.2% Amit Kumar 04 Jun 2025
Catelani Michael 7% $10,662,205 2,468,103 Michael Catelani 05 Jan 2026

As of 30 Sep 2025, 65 institutional investors reported holding 5,413,922 shares of Anixa Biosciences Inc - Common Stock (ANIX). This represents 15% of the company’s total 35,258,614 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Anixa Biosciences Inc - Common Stock (ANIX) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4% 1,422,342 +2.1% 0% $4,693,729
D.A. DAVIDSON & CO. 1.7% 614,272 0% 0.01% $2,027,098
Laird Norton Wetherby Trust Company, LLC 1.7% 597,235 -3.2% 0.34% $1,970,876
UBS Group AG 1.3% 474,480 -6.1% 0% $1,565,784
MISSION WEALTH MANAGEMENT, LP 1% 356,152 -3.6% 0.02% $1,175,302
GEODE CAPITAL MANAGEMENT, LLC 0.97% 343,644 +0.24% 0% $1,134,317
BANK OF AMERICA CORP /DE/ 0.61% 213,955 +1.7% 0% $706,051
BlackRock, Inc. 0.46% 161,022 +0.97% 0% $531,372
STATE STREET CORP 0.34% 120,500 0% 0% $397,650
CITADEL ADVISORS LLC 0.27% 96,010 +35% 0% $316,833
LPL Financial LLC 0.25% 87,005 +16% 0% $287,117
GSA CAPITAL PARTNERS LLP 0.23% 81,897 +4.9% 0.02% $270,000
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.23% 80,387 +378% 0% $265,277
MARSHALL WACE, LLP 0.18% 62,717 +435% 0% $206,967
Bank of New York Mellon Corp 0.17% 58,270 0% 0% $192,291
NORTHERN TRUST CORP 0.16% 56,960 -15% 0% $187,968
CoreCap Advisors, LLC 0.13% 46,787 0% 0.01% $154,397
RENAISSANCE TECHNOLOGIES LLC 0.12% 42,764 +55% 0% $141,121
Prosperity Wealth Management, Inc. 0.12% 41,800 +15% 0.05% $137,940
HighTower Advisors, LLC 0.12% 41,150 +7.9% 0% $135,795
Corient Private Wealth LLC 0.11% 37,400 0% 0% $123,420
Gemmer Asset Management LLC 0.1% 35,000 0% 0.01% $115,500
Westside Investment Management, Inc. 0.1% 35,000 0% 0.02% $115,500
Kestra Advisory Services, LLC 0.07% 24,000 +41% 0% $79,200
NATIONS FINANCIAL GROUP INC, /IA/ /ADV 0.06% 22,500 0% 0% $74,250

Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 74,115 $231,239 +$594 $3.12 4
2025 Q3 5,413,922 $17,872,434 +$304,259 $3.30 65
2025 Q2 5,349,047 $17,648,439 -$787,212 $3.30 65
2025 Q1 5,605,891 $16,030,193 -$524,324 $2.86 57
2024 Q4 5,841,305 $13,552,284 +$544,864 $2.32 57
2024 Q3 5,576,916 $17,555,837 +$106,953 $3.15 56
2024 Q2 5,565,637 $12,300,146 +$344,963 $2.21 52
2024 Q1 5,283,801 $16,487,763 +$2,705,766 $3.12 58
2023 Q4 4,420,722 $17,152,699 +$1,892,994 $3.88 55
2023 Q3 3,928,249 $12,844,861 +$921,910 $3.27 49
2023 Q2 3,647,399 $11,674,122 -$399,198 $3.20 45
2023 Q1 3,664,627 $15,755,697 +$369,660 $4.30 44
2022 Q4 3,636,173 $15,451,565 +$553,415 $4.25 49
2022 Q3 3,474,510 $17,089,377 +$1,187,300 $4.92 41
2022 Q2 3,267,227 $9,991,989 -$78,782 $3.06 42
2022 Q1 3,302,911 $9,050,644 -$407,464 $2.74 37
2021 Q4 3,436,723 $10,208,000 +$525,035 $2.97 39
2021 Q3 3,177,493 $15,156,000 +$1,098,635 $4.77 34
2021 Q2 2,951,398 $11,453,000 -$36,263,645 $3.88 29
2021 Q1 2,512,086 $49,594,000 +$41,200,982 $4.68 27
2020 Q4 1,800,328 $5,527,000 +$13,066 $3.07 20
2020 Q3 1,825,831 $4,439,000 +$532,898 $2.43 19
2020 Q2 1,596,826 $4,888,000 +$720,757 $3.06 18
2020 Q1 1,382,434 $2,197,000 +$44,107 $1.59 15
2019 Q4 1,327,691 $4,354,000 +$51,850 $3.28 14
2019 Q3 1,311,710 $5,247,000 +$341,126 $4.00 14
2019 Q2 1,226,425 $4,448,000 -$180,456 $3.63 13
2019 Q1 1,251,395 $5,657,000 +$702,078 $4.52 14
2018 Q4 1,095,942 $4,318,000 +$4,318,000 $3.94 13